NCT03910959

Brief Summary

The aim of this study is to investigate the effects of animal-assisted occupational therapy on patient's consciousness, measured via the achievement of predefined, patient-specific goals. 30 patients in a minimally conscious state will be included in this trial with randomized, controlled cross-over design. Patients will be randomized and allocated to either study arm 1 or 2 with an allocation ratio 1/1. In study arm 1, patients (N=15) receive three weeks of two AAT sessions per week followed by three weeks of two control sessions (TAU) per week. In study arm 2, patients (N=15) receive three weeks of two control sessions (TAU) per week followed by three weeks of two AAT sessions per week. Each session lasts 30 minutes. Goal attainment and secondary outcomes will be measured before the study start (pre-measurement, t0), at the end of the first 3 weeks therapy (post-measurement I, t1), at the start of the second 3 weeks (pre-measurement II, t2) as well as at the study end (post-measurement II, t3).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 8, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 10, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

July 10, 2019

Completed
6.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 8, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 8, 2025

Completed
Last Updated

August 13, 2025

Status Verified

August 1, 2025

Enrollment Period

6.1 years

First QC Date

April 8, 2019

Last Update Submit

August 7, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Amount of goal achievement l: CSR-R

    The goal achievement will be assessed via the JFK Coma Remission Scale revised (CSR-R), with 6 subscales and a total score ranging from 0 to 23 with higher scores indicating better outcomes.

    3 weeks

  • Amount of goal achievement II: BAVESTA

    The goal achievement will be assessed via the Basler Vegetative State Assessment. The scale ranges from 0 to 5 with higher scores indicating better outcomes.

    3 weeks

  • Amount of goal achievement III: VAS

    The goal achievement will also be assessed via a Visual Analogue Scale where a cross can be made on a line (measured in millimeters, ranging from 0 to 25) with higher values indicating better outcome.

    3 weeks

Secondary Outcomes (4)

  • Behavioral reactions

    3 weeks

  • Heart rate

    3 weeks

  • Heart rate variability

    3 weeks

  • Electrodermal activity (Galvanic Skin Response)

    3 weeks

Study Arms (2)

Animal-assisted therapy

EXPERIMENTAL

Patients receive three weeks of two AAT sessions, each lasting ca 30 minutes.

Other: Animal-assisted therapy

treatment as usual

ACTIVE COMPARATOR

Patients receive three weeks of two control sessions, each lasting ca 30 minutes.

Other: Conventional therapy

Interventions

Therapy in the presence and with interaction with an animal. Involved animals can be all species that live at REHAB Basel and are part of the AAT program. All animals are trained for the specific service with vulnerable patients.

Animal-assisted therapy

Parallelled conventional therapy sessions (treatment as usual)

treatment as usual

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Inpatients of REHAB Basel in a minimally conscious state
  • Minimum age of 18 years
  • Informed consent documented by signature by the patient's legal representative

You may not qualify if:

  • Medical contraindications for contact with animals such as allergy, phobia etc.,
  • Enrollment of the investigator, his/her family members, employees and other dependent persons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

REHAB Basel

Basel, Switzerland

Location

MeSH Terms

Conditions

Persistent Vegetative State

Interventions

Animal Assisted Therapy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesUnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPsychotherapyBehavioral Disciplines and ActivitiesHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: The study has a randomized, controlled cross-over design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 8, 2019

First Posted

April 10, 2019

Study Start

July 10, 2019

Primary Completion

August 8, 2025

Study Completion

August 8, 2025

Last Updated

August 13, 2025

Record last verified: 2025-08

Locations